Frank E Thomas bought $22K of LRMR stock

Frank E Thomas, Dir of Larimar Therapeutics, Inc. (LRMR), bought 8,000 shares of LRMR stock worth $22K, per an SEC Form 4 filed Nov 12, 2026.

It was an open-market purchase.

The trade happened on Nov 11, 2026, 1 day before it was made public.

LRMR has moved +10.6% since the trade date, from $2.73 to $3.02 (Nov 13, 2026 close).